We Address Unmet Medical Needs to Improve Patient Outcomes and Quality of Life

Recent News

EffRx Pharmaceuticals SA Signs Exclusive License Agreement with Pharmaxis for the Registration and Commercialization of Bronchitol® in Switzerland

See all news

Our Products

The product portfolio is led by already launched Binosto® for the treatment of postmenopausal osteoporosis.

See all products

Partnering with Us

Our strategy relies on partnerships for shared commercial success. We welcome you to find out more about partnering.

Get in touch